{"disease":{"id":"hyperinsulinism","name":"Hyperinsulinism","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"octreotide","indication_name":"Congenital hyperinsulinism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sandostatin","generic_name":"OCTREOTIDE","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Somatostatin receptor type 2","drug_class":"Somatostatin Analog","quality_score":75,"revenue":"305","mechanism":"Sandostatin works by mimicking the natural hormone somatostatin to inhibit the release of various hormones and growth factors."},{"drug_id":"diazoxide","indication_name":"Hyperinsulinism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Proglycem","generic_name":"DIAZOXIDE","company_name":"","drug_phase":"marketed","molecular_target":"Sulfonylurea receptor 1, Kir6.2","drug_class":"diazoxide","quality_score":55,"revenue":null,"mechanism":"Proglycem works by blocking the ATP-sensitive potassium channel, which helps to increase blood sugar levels and reduce insulin secretion."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT03042416","title":"18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT05543083","title":"Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Colorado State University","has_results":false},{"nct_id":"NCT06889454","title":"Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Attikon Hospital","has_results":false},{"nct_id":"NCT05088798","title":"Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT04744896","title":"Effects Of Combined Cryolipolysis And High Intensity Interval Training On Insulin Resistance And Body Composition In Polycystic Ovarian Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT06208215","title":"RZ358 Treatment for Congenital Hyperinsulinism","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":56,"lead_sponsor_name":"Rezolute","has_results":false},{"nct_id":"NCT04205604","title":"18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Miguel Pampaloni","has_results":false},{"nct_id":"NCT06478121","title":"Understanding Beta Cell Disorders Through the Study of Rare Genotypes (ENDURE)","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of Exeter","has_results":false},{"nct_id":"NCT03941236","title":"Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":42,"lead_sponsor_name":"Zealand Pharma","has_results":false},{"nct_id":"NCT03768518","title":"GLP-1 Receptor Expression in CHI","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT04327245","title":"To Compare the Effects of Non-nutritive Sweeteners Intake in Woman With Insulin Resistance","phase":"NA","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"University of Chile","has_results":false},{"nct_id":"NCT03777176","title":"A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Zealand Pharma","has_results":true},{"nct_id":"NCT05753657","title":"A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Rambam Health Care Campus","has_results":false},{"nct_id":"NCT05329337","title":"Link Between the Peripheral Mononuclear Cells' Capacity to Induce Insulin Resistance and Hyperinsulinemia","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nīmes","has_results":false},{"nct_id":"NCT04909333","title":"Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT05764200","title":"Acute Microbial Switch","phase":"NA","overall_status":"RECRUITING","enrollment_count":28,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT04538989","title":"An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital Hyperinsulinism","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Rezolute","has_results":true},{"nct_id":"NCT03358745","title":"Impact of Meal Order on Postprandial Cardiometabolic Risk Markers","phase":"NA","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Lund University","has_results":false},{"nct_id":"NCT04732416","title":"HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":16,"lead_sponsor_name":"Hanmi Pharmaceutical Company Limited","has_results":false},{"nct_id":"NCT00835328","title":"Effect of Exendin (9-39) on Glucose Requirements to Maintain Euglycemia","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":14,"lead_sponsor_name":"Diva De Leon","has_results":true},{"nct_id":"NCT03797222","title":"Vitamin E Supplementation in Hyperinsulinism/Hyperammonemia Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Elizabeth A Rosenfeld","has_results":true},{"nct_id":"NCT05528874","title":"NUTRACORE, Glycaemic Index and Appetite","phase":"NA","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Azienda Ospedaliero Universitaria Maggiore della Carita","has_results":false},{"nct_id":"NCT05774613","title":"Effect of Hibiscus Sabdariffa Beverage","phase":"NA","overall_status":"UNKNOWN","enrollment_count":12,"lead_sponsor_name":"Instituto Tecnológico y de Estudios Superiores de Occidente","has_results":false},{"nct_id":"NCT04172441","title":"Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Zealand Pharma","has_results":true},{"nct_id":"NCT04846751","title":"Exercise Type That Faster Reduces Postprandial Glycemia.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":11,"lead_sponsor_name":"University of Castilla-La Mancha","has_results":false},{"nct_id":"NCT03303196","title":"Bionic Pancreas in Children With Hyperinsulinism and Post-Pancreatectomy Diabetes","phase":"NA","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":true},{"nct_id":"NCT03856606","title":"The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia","phase":"NA","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"University of Texas at Austin","has_results":false},{"nct_id":"NCT06363929","title":"Continuous Glucose Monitoring in Neonatal Hyperinsulinism","phase":"","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"MemorialCare Health System","has_results":false},{"nct_id":"NCT02524639","title":"Sirolimus for the Treatment of Hyperinsulinism","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT04062890","title":"Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Arizona","has_results":false},{"nct_id":"NCT02533219","title":"Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Baylor College of Medicine","has_results":false},{"nct_id":"NCT02835131","title":"Compassionate Use of SOM230 for Hyperinsulinemic/Hypoglycemia","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Montefiore Medical Center","has_results":false},{"nct_id":"NCT07262970","title":"Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Rezolute","has_results":false},{"nct_id":"NCT01916148","title":"18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false}],"total":35},"guidelines":[],"source":"Drug Landscape verified database"}